NIR-II-activated biocompatible hollow nanocarbons for cancer photothermal therapy.
Zhourui XuYinling ZhangWeixiao ZhouLijian WangGaixia XuMingze MaFenghua LiuZan WangYucheng WangTiantian KongBinyuan ZhaoWeiping WuChengbin YangPublished in: Journal of nanobiotechnology (2021)
Photothermal therapy has attracted extensive attentions in cancer treatment due to its precise spatial-temporal controllability, minimal invasiveness, and negligible side effects. However, two major deficiencies, unsatisfactory heat conversion efficiency and limited tissue penetration depth, hugely impeded its clinical application. In this work, hollow carbon nanosphere modified with polyethylene glycol-graft-polyethylenimine (HPP) was elaborately synthesized. The synthesized HPP owns outstanding physical properties as a photothermal agent, such as uniform core-shell structure, good biocompatibility and excellent heat conversion efficiency. Upon NIR-II laser irradiation, the intracellular HPP shows excellent photothermal activity towards cancer cell killing. In addition, depending on the large internal cavity of HPP, the extended biomedical application as drug carrier was also demonstrated. In general, the synthesized HPP holds a great potential in NIR-II laser-activated cancer photothermal therapy.
Keyphrases
- drug release
- photodynamic therapy
- papillary thyroid
- drug delivery
- fluorescence imaging
- squamous cell
- fluorescent probe
- heat stress
- cancer therapy
- physical activity
- childhood cancer
- lymph node metastasis
- high speed
- optical coherence tomography
- squamous cell carcinoma
- young adults
- molecularly imprinted
- ionic liquid
- emergency department
- radiation therapy
- simultaneous determination
- electronic health record